Department of Neuropsychiatry, Seoul National University Hospital, Seoul, Republic of Korea.
Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea.
Clin EEG Neurosci. 2020 Jul;51(4):252-258. doi: 10.1177/1550059418815228. Epub 2018 Nov 25.
. The reduced amplitude, prolonged latency, and increased intertrial variability of auditory P300 have been consistently reported in relation to the symptomatic severity of schizophrenia. This study investigated whether auditory P300 event-related potentials can be used as an objective indicator of symptomatic improvement by transcranial direct current stimulation (tDCS) in patients with schizophrenia. . Ten patients with schizophrenia received 20 minutes of 2-mA tDCS twice a day for 5 consecutive weekdays. The anode was placed over the left dorsolateral prefrontal cortex, and the cathode was placed over the left temporo-parietal cortex. The Positive and Negative Syndrome Scale (PANSS) and the auditory P300 were measured for each participant at baseline and after the completion of the tDCS applications. . The participants showed significant improvement in the positive and negative symptoms as indexed by change in the PANSS scores by the tDCS. The P300 amplitude, latency, and intertrial variability did not statistically significantly differ after the tDCS application. However, a significant association was observed between the reduced P300 intertrial variability and improvement in the positive symptoms by tDCS. In addition, the changes in both the P300 latency and intertrial variability were significantly correlated with reduced negative symptoms after the tDCS application. . Although this pilot study is limited by the small sample size and lack of a sham control, the results suggest that auditory P300 may be a putative marker reflecting the effect of tDCS on the positive and negative symptoms of schizophrenia.
. 研究表明,与精神分裂症症状的严重程度相关,听觉 P300 的幅度降低、潜伏期延长和试验间变异性增加。本研究旨在探讨经颅直流电刺激(tDCS)是否可作为精神分裂症患者症状改善的客观指标。. 10 名精神分裂症患者接受了为期 5 天、每天 2 次、每次 20 分钟的 2 mA tDCS 治疗。阳极置于左侧背外侧前额皮质,阴极置于左颞顶皮质。在基线和 tDCS 治疗完成后,对每位参与者进行阳性和阴性症状量表(PANSS)和听觉 P300 测量。. 结果显示,tDCS 可显著改善患者的阳性和阴性症状,PANSS 评分降低。tDCS 治疗后,P300 波幅、潜伏期和试验间变异性无统计学差异。然而,P300 试验间变异性的降低与 tDCS 改善阳性症状显著相关。此外,tDCS 治疗后 P300 潜伏期和试验间变异性的变化与阴性症状的减轻显著相关。. 尽管这项初步研究受到样本量小和缺乏假刺激对照的限制,但结果表明,听觉 P300 可能是反映 tDCS 对精神分裂症阳性和阴性症状影响的潜在标志物。